Author:
Belokoskova S. G.,Tsikunov S. G.
Publisher
Springer Science and Business Media LLC
Reference127 articles.
1. G. V. Beznin, S. G. Belokoskova, and S. G. Tsikunov, “Effects of 1-deamino-8-D-arginine-vasopressin on the development of behavioral and structural-functional disorders caused by vital stress in rats,” Med. Akad. Zh., 16, No. 4, 14–15 (2016).
2. S. G. Belokoskova, I. A. Enaldieva, and S. G. Tsikunov, “Effect of B2 vasopressin receptor analog, 1-deamino-8-D-arginine-vasopressin, on sensory impairments in patients with stroke,” Obz. Klin. Farmakol. Lek. Ter., 13, No. 1, 62–68 (2015).
3. S. G. Belokoskova, D. V. Kritskaya, G. V. Beznin, et al., “1-Deamino-8-D-arginine-vasopressin increases plasma levels of brain-derived neurotrophic factor (BDNF) in rats in a model of post-traumatic stress disorder,” Med. Akad. Zh., 20, No. 4, 27–34 (2020), https://doi.org/10.17816/MAJ46393.
4. S. G. Belokoskova, I. I. Stepanov, and S. G. Tsikunov, “A vasopressin B2 receptor agonist reduces depressive disorders in post-stroke patients,” Vestn. Ross. Akad. Med. Nauk., No. 4, 40–44 (2012).
5. S. G. Belokoskova and S. G. Tsikunov, “Activation of B2 vasopressin receptors induces recovery of motor functions in patients with stroke, Parkinson’s disease and parkinsonism of various origins,” Obz. Klin. Farmakol. Lek. Ter., 14, No. 4, 52−60 (2016), https://doi.org/10.17816/RCF14452-60.